Engineered and Banked iPSCs for Advanced NK and T Cell Immunotherapies

By
Bob
-
0
241
The authors highlight recent progress in induced pluripotent stem cells (iPSCs) editing and guided differentiation to develop natural killer (NK) and T cell products for immunotherapy.
[Blood]
Abstract